Clario
Phase 2/3Clario generates the richest clinical evidence by fusing our deep scientific expertise and global scale into the broadest endpoint technology platform.
Founded
2015
Focus
Digital HealthAI / Machine Learning
About
Clario generates the richest clinical evidence by fusing our deep scientific expertise and global scale into the broadest endpoint technology platform.
Funding History
2Total raised: $350M
Series A$150MEQTJun 15, 2021
Debt$200MGoldman SachsJun 15, 2021
Company Info
TypePrivate
Founded2015
LocationPhiladelphia, United States
StagePhase 2/3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile